BioMed Research International / 2015 / Article / Tab 2 / Research Article
The Role of FGFR1 Gene Amplification as a Poor Prognostic Factor in Squamous Cell Lung Cancer: A Meta-Analysis of Published Data Table 2 Patients’ number of clinical characteristics.
Histology Gender Smoking pStage SQCC ADE Male Female C N F III-IV I-II Seo et al. [29 ] 139 230 251 118 127 142 — 264 105 Cihoric et al. [26 ] 169 137 244 85 239 18 — — — Toschi et al. [30 ] 138 243 369 76 — — — 265 180 Russell et al. [31 ] 178 117 222 130 69 258 223 261 91 Gadgeel et al. [22 ] 136 169 226 119 270 37 — — — Craddock et al. [38 ] — — 77 44 43 65 61 89 32 Tran et al. [24 ] 101 115 169 95 165 9 — 223 41 Kim et al. [25 ] — — 245 17 107 155 — 198 64 Heist et al. [40 ] — — 128 98 45 181 172 155 61 Kohler et al. [28 ] 133 64 — — — — — — — Sasaki et al. [23 ] — — 71 29 76 24 — — — Weiss et al. [27 ] — — — — — — — — — Overall — — — — — — — — —
SQCC, squamous cell lung cancer; ADE, lung adenocarcinoma; C, current smokers; N, never smokers; F, former smokers; pStage, pathological stage. Pathological stage or clinical stage, not specified.